Business Services Global On demand · 24-48h

Global Genetically Modified Organisms (GMO) Testing Services Market Strategic Research Report

Global Genetically Modified Organisms (GMO) Testing Services…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Genetically Modified Organisms (GMO) Testing Services Market
$2.33B2025
8.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Polymerase Chain Reaction, Lateral Flow Devices, ELISA Test, Herbicide Tolerance, Insect Resistance, Others

By Application: Rapeseed/Canola, Tomato, Soy, Corn, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: AgEtal, Alfa Chemistry, ALS Limited, Ayub Agricultural Research Institute (AARI), Bio-Rad Laboratories, Inc., Bioscience, Bureau Veritas SA, BVAQ, Centre Testing International(CTI), EMSL Analytical Inc., EnviroLogix, Eurofins Scientific SE, Genetic ID NA, Inc., Intertek Group Plc., Mérieux NutriSciences Corporation, Microbac Laboratories, Inc., Middle East Testing Services (METS), Monsanto (Bayer AG), OMIC USA Inc., Romer Labs, SGS SA, STC, Thermo Fisher Scientific Inc., TÜV SÜD AG

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 141 pages
Market size 2025
$2.33B
Billion USD
Forecast CAGR
8.1%
2025-2032
Forecast 2032
$4B
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Genetically Modified Organisms (GMO) Testing Services market size is predicted to grow from US$ 2,331 million in 2025 to US$ 3,981 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.

Genetically modified organisms (GMO) testing services refer to the process of checking the nutritional level of GM crops, meats, and foods. The GM products are mainly derived through certain modifications of original seeds of crops using various biotechnological methods to ensure a high yield of crops.

As per the 2020 report by the Food and Agriculture Organization (FAO), nearly 55% of the total global production of maize was used as animal feeds, 20% for other non-food applications, and only 12% used as food products. In 2021, the US stood as the largest genetically modified crops producer, accounting for more than 37% of the total global production that covered several crops including soybeans, cotton, corn, apples, canola, sugar beets, papaya, and potatoes. The US farmers used more than 170 million acres of agricultural land for different GMO crops farming in 2019. As claimed by various scientific communities, the rising production of biotech crops globally aided in the alleviation of various global issues such as food insecurity, poverty & malnutrition, and climate change. However, as many as 39% of consumers in the US still believe that GM foods are less healthy compared to non-GM foods.

This report presents a comprehensive overview of the global Genetically Modified Organisms (GMO) Testing Services market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Polymerase Chain Reaction
  • Lateral Flow Devices
  • ELISA Test
  • Herbicide Tolerance
  • Insect Resistance
  • Others

Segment by Application

  • Rapeseed/Canola
  • Tomato
  • Soy
  • Corn
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Genetically Modified Organisms (GMO) Testing Services market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Rapeseed/Canola, Tomato, Soy evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Genetically Modified Organisms (GMO) Testing Services Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.33B
2025
Forecast
$4B
2032
CAGR
8.1%
2025–2032
Gebieden
5
global
Key companies
AgEtalAlfa ChemistryALS LimitedAyub Agricultural Research Institute (AARI)Bio-Rad Laboratories, Inc.BioscienceBureau Veritas SABVAQ
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Polymerase Chain ReactionLateral Flow DevicesELISA TestHerbicide ToleranceInsect ResistanceOthers
By Application
Rapeseed/CanolaTomatoSoyCornOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Polymerase Chain Reaction
  • 3.1.3 Lateral Flow Devices
  • 3.1.4 ELISA Test
  • 3.1.5 Herbicide Tolerance
  • 3.1.6 Insect Resistance
  • 3.1.7 Others
  • 3.1.8 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Rapeseed/Canola
  • 4.1.3 Tomato
  • 4.1.4 Soy
  • 4.1.5 Corn
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 AgEtal
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Alfa Chemistry
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 ALS Limited
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Ayub Agricultural Research Institute (AARI)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Bio-Rad Laboratories, Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Bioscience
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Bureau Veritas SA
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 BVAQ
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Centre Testing International(CTI)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 EMSL Analytical Inc.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 EnviroLogix
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Eurofins Scientific SE
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Genetic ID NA, Inc.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Intertek Group Plc.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Mérieux NutriSciences Corporation
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Microbac Laboratories, Inc.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Middle East Testing Services (METS)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Monsanto (Bayer AG)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 OMIC USA Inc.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Romer Labs
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 SGS SA
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 STC
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Thermo Fisher Scientific Inc.
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 TÜV SÜD AG
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Genetically Modified Organisms (GMO) Testing Services market size?
The global Genetically Modified Organisms (GMO) Testing Services market is estimated at US$ 2.33 billion in 2025 (base year) and is projected to reach US$ 3.98 billion by 2032.
What growth rate is expected for the Genetically Modified Organisms (GMO) Testing Services market through 2032?
The market is expected to grow at a CAGR of 8.1% from 2026 to 2032, expanding from US$ 2.33 billion in 2025 to US$ 3.98 billion in 2032, roughly 1.7 times its base-year value.
How is Genetically Modified Organisms (GMO) Testing Services defined?
Genetically modified organisms (GMO) testing services refer to the process of checking the nutritional level of GM crops, meats, and foods. The GM products are mainly derived through certain modifications of original seeds of crops using various biotechnological methods to ensure a high yield of crops.
What are the main segments of the Genetically Modified Organisms (GMO) Testing Services market by type?
By type, the market is segmented into Polymerase Chain Reaction, Lateral Flow Devices, ELISA Test, Herbicide Tolerance, Insect Resistance and Others.
Which applications drive demand in the Genetically Modified Organisms (GMO) Testing Services market?
Key applications covered include Rapeseed/Canola, Tomato, Soy, Corn and Others.
Who are the key players in the Genetically Modified Organisms (GMO) Testing Services market?
Key players profiled include AgEtal, Alfa Chemistry, ALS Limited, Ayub Agricultural Research Institute (AARI), Bio-Rad Laboratories, Bioscience, Bureau Veritas SA and BVAQ, among 24 companies covered in total.
Which regions and countries are covered for Genetically Modified Organisms (GMO) Testing Services?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Genetically Modified Organisms (GMO) Testing Services market report?
The report is intended for manufacturers and solution providers, distributors and end users in Rapeseed/Canola, Tomato and Soy, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Genetically Modified Organisms (GMO) Testing Services market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.